BLOCKBUSTER PIPELINE !

The purpose of this new thread is to celebrate new pipeline products so ok lets hear it for Leadership. We all know that inbrija is there but also others are coming.

 

2024 is going to be so awesome!

 

LOOK YOU IDIOT DR C HAS MANY NEXT YEAR ! !! ! !!

 

Habib at least lie convincingly.

ACOR has one product filed and possibly launching next year and that is inhaled LD, which should have launched already but Ronnie and crew blew it.

All other pipeline compounds are going to take a minimum of five to six years to complete studies, file and get approved. Of course you are well aware of this and continue to lie to people. Not that facts ever get in your way. It’s almost like you are paid to post nonsense....

 

Word has it that the interns were involved in the filing. Hard to believe but is plausible.

 

No way you know the new accelerated approval process will expedite the approvals ,of 4 or 5 and also experimentals can be prescribed. so ok we are going to explode here with prosperity

 

Habib you really dug deep for this load of crap.

Let’s assume you demonstrate something novel and get expedited review. This may shave six months off your approval timeline. Here’s the catch, you still have to enroll the studies which is getting progressivley harder and more costly in MS and Migraine given all that is out there and coming ahead of you.

As for prescribing experimental medications, that is laughable that you would think this would add to revenue in any meaningful way. Compassionate use is usually either free or a nominal fee to cover costs. One thing you might consider with your vast knowledge is that this also opens the door for safety signals that are different from the trial population and could jeopardize your approval altogether. How are the experimental prescriptions going for inhaled LD?

Stick to made up PR, you don’t know crap about this industry, which is probably what allows you to post such nonsense so frequently.

See you in 2024

 

most of this is correct. But dude. Stop saying “Habib”, it’s really stupid and not funny. No one thinks it’s funny you’re trying to hard.

 

Look Dickhead everything you spout is the OLD way so ok now we have accelerated process with international approvals over FDA. YOU DONT GIT IT so don't make stupid post

 

Amen bro love this company and leaders

 

2024 Habib.

EU markets are worth 1/4of the US. Don’t give a crap if you get approval in 2023 over there. It makes no difference to the revenue woes of ACOR.

Your anger proves you know this.

 

THE CHINESE MARKET will be yuge!!! You don't git it !! Will carry us for a decade so look at new market initiatives in HK and Shanghai you moron!!!!

 

But will trade tariffs effect this? We know the Asia market is very big with 2 Billion potential patients, but do we have access to them? Is the Asian marketing team effective here? What about India?? Another .7 Billion patients??

Looks like the naysayers are dead wrong about leadership !

 

If you are banking on China, you are even more delusional than I suspected.

Are there a ton of patients? Sure, is China going to allow your pricing and aid access? Not a chance. See how quickly they invalidate your patent and allow knock offs Habib.

You are once again speaking like an MBA. Full of analysis, but lacking experience.

2024.

 

Your stupidness grows until it is bigger than your head. We have made more success with inhaled product than you can be knowing about. January is when the best products launch for rapid success and we are doing this. Stop with name calling and answer one question. Our leaders are beyond the Company with appointments at BIO itself. Knowing this do you now apologize to our leaders and work hard again ?

 

So sorry you do not understand the elastic supply vs demand push curve in Bio. Pharma. With degrees in Economics and the MBA from top Chicago so ok I understand you not git the Leadership's strategy to monetize the pipeline in ASia as well as domestic approvals being accelerated. Academic study superior to 'gut' knowledge my friend.

 

obviously a well qualified member of co, but practical experience also helps somewhat

 

Glad to see the top level economist persona is back Habib. Wash, rinse and repeat with the rhetoric.

Here’s the problem, you don’t have accelerated approval and no agreement on alternate markers. You do have a delayed program with an inhalation system that has never been reviewed so it is likely to raise more questions (and has). Good luck with proof in patients with reduced lung function (no data).

You can rely on as many countries as you want to bolster the perceived need, however their approaches to care and payment for it is not in your favor.

ALl you have done is highlight the failure in our academic system with your rants.

2024!

 

You deliberately obfuscate the plan of Leadership. Accelerated approvals here, then Asia, Latin America and Europe follow, and there we are. No need to complicate a very simple process and scare the rank and file so ok let the good time role as Leadership under our CEO has it all under control.

 

Do you people honestly believe these threads? They are posted positively' b/c Ronnie is trying to sell the dumb product he has as a last salvation. They are restructuring the field layoffs will soon happen. This place is on its last thread. Poor leadership. Marketing is awful, managed care weak, training weak. ABMs not even working